← Leaderboards
Tina Costacou
University Of Pittsburgh At Pittsburgh
$2,896,697
Attributed
$2,896,697
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $785.9K · FY2009–19$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,896,697 · 3
By mechanism
R01$2,487,671 · 2
R21$409,026 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Michael R Pinsky$13,601,966
- Trevor J. Orchard$23,296,930
- Solomon Fiifi Ofori-Acquah$18,588,176
- David J. Fink$11,160,913
- Nahmah Kim-Campbell$842,168
Others in their field
Top investigators on “Cohort”
- David R. Weir · University Of Michigan At Ann Arbor$406,814,098
- George R Seage · Abt Associates, Inc.$297,656,361
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
CohortCoronary ArteriosclerosisComplications Of Diabetes MellitusFunctional DisorderEpidemiologyFollow-UpOxidationRisk FactorsInflammationInsulin-Dependent Diabetes MellitusHaptoglobinsGenotypeIncidenceReportingHemoglobinOxidative StressAcute-Phase ProteinsPreventGenesGenderLightDisorder RiskExhibitsDiabetes Mellitus
Grant awards (7)
Epidemiology of Diabetes Complications (EDC) Phase II: Renewal$454,882
R01 · FY2019 · DK · contact PI
Re-evaluating the role of HDL in coronary artery disease (RETRO HDL)$331,021
R01 · FY2019 · HL · contact PI
Re-evaluating the role of HDL in coronary artery disease (RETRO HDL)$531,212
R01 · FY2018 · HL · contact PI
Re-evaluating the role of HDL in coronary artery disease (RETRO HDL)$584,898
R01 · FY2017 · HL · contact PI
Re-evaluating the role of HDL in coronary artery disease (RETRO HDL)$585,658
R01 · FY2016 · HL · contact PI
Oxidative insults, antioxidative responses and type 1 diabetes complications$148,917
R21 · FY2010 · DK · contact PI
Oxidative insults, antioxidative responses and type 1 diabetes complications$260,109
R21 · FY2009 · DK · contact PI